EDGAR·FLOW

Vital Farms, Inc. — Form 8-K

Filed August 6, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 72/100
What the filing says
Vital Farms reported Q2 2026 net revenue of $166.0M (down 10.1% YoY) with a net loss of $31.1M versus prior-year net income of $16.6M, driven by industry-wide egg oversupply and $19.5M in excess breaker sales at depressed prices. Gross margin collapsed to 6.6% from 38.9% YoY. The company closed new credit facilities: a $125M 3-year term loan and a $60M 3-year asset-based lending facility, replacing prior revolving credit. On August 3, 2026, the Board terminated the stock repurchase program (1.1M shares at $13.29/share had been repurchased for $15.0M in Q2). Cash declined to $21.2M from $48.8M at year-end 2025. Full-year FY2026 guidance maintained: $775M–$800M revenue and $0M–$10M Adjusted EBITDA, assuming oversupply costs of mid-$30M range.
Why this rating

Severe margin compression (32.3 percentage points) and swing to loss material for $1.4B company; new debt and liquidity measures offset severity. Guidance reaffirmed but oversupply headwinds ongoing.

View original filing on SEC.gov ↗ VITL · stock on Yahoo Finance ↗

See more from August 6, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.